Monitoring possible adverse events from drugs: The role and protections provided by the HPRA in Ireland
Ireland has a comprehensive system of monitoring medicinal drugs already in use through a body called the the Health Products Regulatory Authority (HPRA) www.hpra.ie.
If any evidence of serious side effects from any drugs become known and authenticated, the HPRA would issue information and guidance to clinicians, pharmacists and patients and would insist on the drug manufacturer taking action.
CFI has received no such indications from the HPRA or CF clinicians or pharmacists or any other reputable source that there is any such concern about any CF drug in Ireland (beyond the already known and accepted side effects known from extensive drug trials, prior to reimbursement).
In short, patients should not be guided by rumour especially from financial news outlets, which may be aimed at reducing share price for some speculators to make short term gains.
As always CFI will remain vigilant. If any significant problems are flagged to us about any CF drug, our members would be the first to know.